Who owns Vanda Pharmaceuticals Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VNDA from SEC Form 13F filings across 171 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 171 institutions disclosed 49.7M shares of Vanda Pharmaceuticals Inc. worth $304.0M — about 82.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
171
13F holders
$304.0M
value, 2026 filers
82.5%
of shares outstanding (49.7M sh)
30
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VNDA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.7M | $46.8M | 0.0% | 12.7% | +5.2% |
| 2 | STATE STREET CORP | 3.5M | $21.5M | 0.0% | 5.8% | +16.6% |
| 3 | AQR CAPITAL MANAGEMENT LLC | 3.5M | $21.4M | 0.0% | 5.8% | +118.1% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 3.4M | $21.1M | 0.0% | 5.7% | -8.5% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $15.4M | 0.0% | 4.2% | +1.7% |
| 6 | AIGH Capital Management LLC | 2.0M | $12.5M | 0.8% | 3.4% | -25.7% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 1.9M | $11.7M | 0.0% | 3.2% | +6.8% |
| 8 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $10.6M | 0.0% | 2.9% | -2.5% |
| 9 | MILLENNIUM MANAGEMENT LLC | 1.6M | $9.8M | 0.0% | 2.7% | -14.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $9.1M | 0.0% | 2.5% | +2.8% |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.3M | $8.3M | 0.0% | 2.2% | -3.5% |
| 12 | MARSHALL WACE, LLP | 1.2M | $7.5M | 0.0% | 2% | +105.7% |
| 13 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.2M | $7.4M | 0.0% | 2% | +3.8% |
| 14 | Krensavage Asset Management, LLC | 1.2M | $7.2M | 2.7% | 2% | 0.0% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $6.9M | 0.0% | 1.9% | +11.5% |
| 16 | GOLDMAN SACHS GROUP INC | 1.0M | $6.3M | 0.0% | 1.7% | +23.6% |
| 17 | CITADEL ADVISORS LLC | 758,302 | $4.6M | 0.0% | 1.3% | +19.7% |
| 18 | Qube Research & Technologies LtdNEW | 729,212 | $4.5M | 0.0% | 1.2% | new |
| 19 | FEDERATED HERMES, INC. | 714,278 | $4.4M | 0.0% | 1.2% | +24.1% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 646,256 | $4.0M | 0.0% | 1.1% | +17.1% |
| 21 | NORTHERN TRUST CORP | 600,619 | $3.7M | 0.0% | 1% | +33.2% |
| 22 | MORGAN STANLEY | 477,974 | $2.9M | 0.0% | 0.8% | +8.4% |
| 23 | Lionhunter Capital Management, LLCNEW | 400,245 | $2.4M | 1.1% | 0.7% | new |
| 24 | VANGUARD FIDUCIARY TRUST CO | 399,817 | $2.4M | 0.0% | 0.7% | +3.1% |
| 25 | Jump Financial, LLC | 339,907 | $2.1M | 0.0% | 0.6% | +70.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.